plerixafor GZ316455

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

LymphomaMultiple Myeloma

Phase 2

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

CompletedNCT02221479

Genzyme, a Sanofi CompanyMultiple Myeloma

Start: 2014-10-31End: 2015-07-31Updated: 2015-08-04

Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma

CompletedNCT02221492

Genzyme, a Sanofi CompanyLymphoma

Start: 2014-11-30End: 2016-03-31Updated: 2016-03-30

Related Papers

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study.

2018-07-2411 citations